Brookfield Asset Management - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 439 filers reported holding REPLIGEN CORP in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Brookfield Asset Management ownership history of REPLIGEN CORP
ValueSharesWeighting
Q2 2023$501,617
-63.3%
3,546
-56.4%
0.00%
-60.0%
Q1 2023$1,368,430
-62.1%
8,128
-63.5%
0.01%
-66.7%
Q2 2022$3,614,000
+60.4%
22,251
+185.4%
0.02%
+66.7%
Q3 2021$2,253,000
+62.8%
7,797
+12.5%
0.01%
+50.0%
Q2 2021$1,384,0006,9310.01%
Other shareholders
REPLIGEN CORP shareholders Q1 2023
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders